WO2002004627A1 - Procede hautement efficaces permettant de fabriquer des sondes d'arn - Google Patents

Procede hautement efficaces permettant de fabriquer des sondes d'arn Download PDF

Info

Publication number
WO2002004627A1
WO2002004627A1 PCT/JP2001/005837 JP0105837W WO0204627A1 WO 2002004627 A1 WO2002004627 A1 WO 2002004627A1 JP 0105837 W JP0105837 W JP 0105837W WO 0204627 A1 WO0204627 A1 WO 0204627A1
Authority
WO
WIPO (PCT)
Prior art keywords
rna
chain reaction
polymerase chain
polymerase
probe
Prior art date
Application number
PCT/JP2001/005837
Other languages
English (en)
Japanese (ja)
Inventor
Kaoru Kikuchi
Toru Kimura
Original Assignee
Sumitomo Pharmaceuticals Company, Limited.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Company, Limited. filed Critical Sumitomo Pharmaceuticals Company, Limited.
Priority to AU2001269451A priority Critical patent/AU2001269451A1/en
Publication of WO2002004627A1 publication Critical patent/WO2002004627A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Definitions

  • the present invention relates to a novel method for producing specific RNA probes for a large number of genes simultaneously and in a short time.
  • DNA microarray technology can comprehensively analyze the fluctuation pattern of gene expression between normal and diseased states for thousands to tens of thousands of genes. By this method, a large number of expression-variable genes that can be associated with a disease can be identified at one time. However, among the expression-variable genes identified by the microarray technology, there are genes that cause disease, and genes that have secondary expression fluctuation due to the disease. Therefore, some means is needed to narrow down the “causal gene” of the disease from these expression-variable genes.
  • One of the effective means is to analyze the temporal and spatial expression patterns of expression-variable genes.
  • an in situ hybridization method is often used.
  • a probe (generally, a cRNA probe) is required, and the production of the probe has conventionally been performed by obtaining the cDNA of the target gene and cloning it.
  • the cloning of this cDNA includes (1) incorporation (ligation) of the obtained target gene cDNA into a plasmid having an RNA polymerase recognition sequence (promoter), (2) transformation of E. coli with the plasmid DNA, and (3) transformation of E. coli. Culture of transformed E. coli (recombinant), (4) Extraction and purification of plasmid DNA from E. coli, (5) Confirmation of plasmid DNA incorporating target cDNA (selection of clones) I have. Furthermore, by cutting the plasmid DNA obtained by the above operations (1) to (5) with a restriction enzyme, the plasmid DNA can be used for the first time for the in vitro type II for RNA probe synthesis. Preparation of such RNA probes, including cloning of cDNA, usually required more than one week.
  • An object of the present invention is to provide a novel RNA probe production method capable of producing specific RNA probes for a large number of genes simultaneously and in a short time without going through the DNA cloning step. .
  • a DNA specific to the target gene is obtained by a polymerase chain reaction using a primer having an RNA polymerase recognition sequence (promoter sequence) attached to the 5 ′ end, and the DNA is directly synthesized as an RNA probe.
  • An object of the present invention is to provide a novel method for preparing an RNA probe, which is used as a mirror form of the RNA probe.
  • the DNA containing the sequence of the target gene must have an RNA polymerase recognition sequence (promoter). It was necessary to clone the plasmid DNA downstream (3 'side) of the promoter and clone it.
  • RNA polymerase recognition sequence promoter
  • an oligonucleotide primer having a target sequence of about 20 bp of the target gene was prepared downstream (3 'side) of an RNA polymerase recognition sequence (promoter) such as Pacteriophage T3, ⁇ 7, or SP6.
  • promoter RNA polymerase recognition sequence
  • a promoter sequence derived from a different pacteriophage was added to each of the 5- and 3'-oligonucleotide primers.
  • a polynucleotide (DNA, RNA) derived from a tissue or a cell is used as a material to perform a polymerase chain reaction (reverse transcription-polymerase chain reaction when RNA is a material), and the promoter is used.
  • a DNA having a sequence at the 5 ′ end and containing the target sequence of the target gene was synthesized (referred to as promoter + DNA).
  • the structure of the promoter + DNA synthesized here is the same as the promoter + DNA on the plasmid DNA produced by the conventional method, that is, the component required for in vitro RNA synthesis.
  • FIG. 1 schematically illustrates an example of such an RNA probe production method of the present invention.
  • the novel RNA probe preparation method of the present invention can greatly reduce the time compared to the conventional method including a DNA cloning step, and can handle a large number of genes simultaneously. is there. Specifically, it has the following merits as compared with the conventional method.
  • RNA probes for many genes can be prepared in only 1.5 to 2 days. Can be manufactured.
  • the sequence of the RNA probe must have high specificity to hybridize only to the mRNA of the target gene.
  • a homologous search is performed using a genome sequence database to predict nonspecific binding that hinders the reaction, thereby arbitrarily selecting a highly specific sequence, This can be turned into an RNA probe.
  • the existing cDNA clone contains a region having high homology with other genes, the conventional method may require subcloning of the cDNA omitting this region. With this method, it is possible to select only highly specific sequences as RNA probes without performing subcloning.
  • cDNA clones (EST clones and the like) of many genes are commercially available, but in the method of the present invention, RNA probes can be produced without obtaining such clones.
  • the length of cDNA synthesized by PCR (polymerase chain reaction) or RT-PCR (reverse transcription and polymerase chain reaction) is used to infiltrate the subsequently synthesized RNA probe into the thread. It can be set arbitrarily in consideration of the characteristics and sensitivity. For example, the best results can be obtained with a probe length of 500 b in Honolemount in situ hybridization, but the technique of the present invention can easily produce a probe of a required length.
  • the present invention has been completed based on the above findings.
  • a highly efficient method for producing an RNA probe comprising the following steps (a) and (b):
  • RNA polymerase used for preparing the RNA probe is selected from T3 RNA polymerase, T7 RNA polymerase and SP6 RNA polymerase. High efficiency RNA probe preparation method,
  • RNA probe the method of producing a high-efficiency RNA probe according to any one of (1) to (7), wherein the target gene is a gene whose expression fluctuates between a normal state and a disease state;
  • a reagent kit for producing a high-efficiency RNA probe comprising the oligonucleotide primer or the group thereof according to (11) or (12), or the DNA or the group thereof according to (13);
  • a reagent kit for producing a high-efficiency RNA probe containing the following (i) and (ii):
  • FIG. 1 is a diagram schematically illustrating an example of the method for producing an RNA probe of the present invention.
  • FIG. 2 is a photograph showing the results of in situ hybridization (hole mount method) using cRNA probes of 13 types of genes.
  • E Neuropilin-2
  • F Plexin-Al
  • G Plexin-A3
  • H Netrin-1
  • I DCC
  • J unc-5hl
  • Ephrin ⁇ L Eph-Bl
  • M Neurofilament-M
  • the present invention provides a large number of relics without going through the DNA cloning steps conventionally performed.
  • the present invention provides, for the first time, a high-efficiency RNA probe production method capable of simultaneously producing a specific RNA probe for a gene in a short time. Specifically,
  • RNA probe containing two consecutive steps of a polymerase chain reaction or a reverse transcription-polymerase chain reaction step a
  • RNA synthesis of the DNA obtained by the reaction step b
  • the method corresponds to the method for producing a high-efficiency RNA probe of the present invention.
  • any polynucleotide may be used as long as it is a polynucleotide prepared from an individual tissue or cell.
  • a genome (chromosome) DNA, cDNA or RNA is mentioned.
  • the RNA the total RNA and the level of the mRNA and the deviation thereof can also be used.
  • the genomic DNA and cDNA may be in the form of a library, that is, in a form incorporated in a plasmid, or in a form not incorporated in the plasmid.
  • the positive nucleotide can be easily prepared by those skilled in the art according to, for example, Molecular Cloning, A Laboratory Manual, edited by T Maniatis et al., Second Edition (1989), Cold Spring Harbor Laboratory, and the like.
  • a genomic DNA extraction kit (manufactured by Kuchish Inc .: DNA isolation kit, etc.), a cDNA preparation kit (manufactured by Gibco BRL: Superscript Chiyois System, etc.) And the like are commercially available, and the polynucleotide of the present invention can be easily prepared by using these.
  • genomic DNA, cDNA and RNA prepared from tissues of various animal species are commercially available from, for example, Pyochain or the like, and can be purchased.
  • a polynucleotide derived from an individual tissue or cell is Specific to the target gene by either “polymerase chain reaction (hereinafter sometimes referred to as PCR reaction)” or “reverse transcription and polymerase chain reaction (hereinafter sometimes referred to as RT-PCR reaction)” Synthesize double-stranded DNA.
  • PCR reaction polymerase chain reaction
  • RT-PCR reaction reverse transcription and polymerase chain reaction
  • the starting material is RNA
  • a single-stranded cDNA is synthesized by a reverse transcription reaction, and then a double-stranded DNA specific to the target gene is synthesized by a polymerase chain reaction.
  • ⁇ target gene '' refers to a gene to be analyzed, that is, an object to be subjected to analysis such as in situ hybridization or northern blot hybridization using an RNA probe prepared by the RNA probe preparation method of the present invention.
  • RNA probe preparation method of the present invention refers to the gene Specific examples include the following genes.
  • the target gene as described above can be selected in advance by, for example, DNA microarray technology, differential display, or subtraction.
  • the DNA microarray technology can comprehensively analyze gene expression fluctuation patterns ⁇ between normal and disease states, and gene expression fluctuation patterns between normal and drug administration, for thousands to tens of thousands of genes. You can do it.
  • Those identified as “expression-variable genes” by these techniques are also included in the category of “target genes” in the present invention.
  • the “double-stranded DNA specific to the target gene” synthesized in the step (a) is a double-stranded DNA corresponding to all or a part of the target gene, and a base specific to the target gene. It means a double-stranded DNA consisting of a sequence.
  • the preferred length of the double-stranded DNA is about 100 bp to 5000 bp, more preferably about 500 bp to 2000 bp. The fact that it is “specific” for the target gene will be described later.
  • All of the tide primers contain a nucleotide sequence portion specific to the target gene. That is, in order to prevent the primer from annealing to a gene other than the target gene to synthesize an untargeted DNA, the oligonucleotide primer must contain a nucleotide sequence portion specific to the target gene. .
  • the length of the base sequence portion specific to the target gene in the oligonucleotide primer is preferably about 10 bases to 30 bases, and more preferably about 20 bases.
  • nucleotide sequence “specific” for the target gene means that the nucleotide sequence is not found in the nucleotide sequence of another gene with high homology.
  • a nucleotide sequence specific to a target gene is defined as a sequence of homology between the target gene and another gene, and a homology of at least 80% (preferably at least 95%). It means such a base sequence portion for which no sequence is found.
  • a vast database of human genomic or cDNA sequences has been constructed.
  • Examples of accessible databases include the GenBank database and the EMBL database.
  • the GenBank genome database is effectively used.
  • a homology search using these databases a nucleotide sequence portion specific to the target gene can be specified.
  • the use of a genome sequence database has the advantage that the specificity of a probe can be predicted completely, providing information that is qualitatively different from the past. Therefore, it is preferable to perform a homology search using a registered database of complete genome sequences.
  • NCBI National Center for Generic Analysis
  • BLAST program open the BLAST program. Furthermore, select Human Genome BLAST and enter the sequence of the target gene or the accession number in the database of the target gene and perform homology search. When a similar sequence is found in another gene by homology search, the sequence of the oligonucleotide primer is selected from a sequence portion other than the similar sequence. Verification of specificity by homology search on the database as described above is based on oligonucleotide nucleotide priming. It is preferable to carry out the selection at the time of selection of the primer, but it is also effectively used when verifying that the oligonucleotide primer selected by another means has specificity.
  • the 5'- and 3'-oligonucleotide primers used in the polymerase chain reaction or the reverse transcription and the polymerase chain reaction need to contain a nucleotide sequence specific to the target gene. Stated.
  • RNA polymerase recognition sequence hereinafter sometimes referred to as a promoter
  • RNA polymerase recognition sequence Two strands having the RNA polymerase recognition sequence at the 5 'end by performing polymerase chain reaction or reverse transcription and polymerase chain reaction using an oligonucleotide primer having an RNA polymerase recognition sequence added to the end.
  • Strand DNA is synthesized (hereinafter, the synthesized double-stranded DNA is sometimes referred to as promoter + DNA).
  • the structure of the promoter + DNA synthesized here is equal to the promoter + DNA on the plasmid DNA produced by the conventional method, that is, the component necessary for in vitro RNA synthesis.
  • the obtained promoter + DNA is converted into the in vitro RNA in the step (b) It has the great advantage that it can be used directly for synthesis.
  • the RNA polymerase recognition sequence to be added to the 5 'end of the oligonucleotide primer may be any RNA polymerase recognition sequence available to those skilled in the art. Recognition sequences for phage-derived RNA polymerase are included. Specific examples include a recognition sequence for T3 RNA polymerase, T7 RNA polymerase, or SP6 RNA polymerase. Here, as a specific example of the T3 RNA polymerase recognition sequence, GenBank Acc.
  • RNA polymerase recognition sequence when added to the 5 and 5 ends of an oligonucleotide primer, the RNA polymerase recognition sequence should be added only to the 5 and 5 ends of an oligonucleotide primer according to the purpose. If possible, the RNA polymerase recognition sequence can be added to the 5 'end of both the 5'- and 3'-oligonucleotide primers.
  • the RNA polymerase is used only for the 3′-oligonucleotide primer used in the step (a). You can add a recognition sequence.
  • the RNA probe of the antisense strand is used to detect the expression of the mRNA of the target gene in in situ hybridization or Northern plot hybridization.
  • the 5′- and 3,-used in the step (a) are used. It is necessary to add an RNA polymerase recognition sequence to both oligonucleotide primers.
  • the RNA probe of the antisense strand is used for detecting the expression of the mRNA of the target gene in in situ hybridization and Northern blot hybridization as described above, while the RNA probe of the sense strand is It is used as a control for detecting the expression of knock background.
  • antisense strand means having a sequence complementary to raRNA that defines the amino acid sequence of the protein, and the “sense strand” means having the same sequence as the mRNA.
  • each primer be provided with a recognition sequence for RNA polymerase derived from a different species. That is, since the recognition sequences for different RA polymerases are added to the 5′- and 3, -oligonucleotide primers, the sense strand RNA and the antisense strand RNA are separated in step (b). It has the great advantage that it can be synthesized (independently). Examples of combinations of the RNA polymerase recognition sequence (promoter) added to the 5′- and 3′-oligonucleotide primers are as follows. However, the present invention is not limited to this example, and it is sufficient if the promoters on both the 5 ′ and 3 ′ primers can be recognized by different RNA polymerases.
  • SP6 promoter / T7 promoter Techniques for performing the polymerase chain reaction or the reverse transcription and polymerase chain reactions using the 5,-and 3, -oligonucleotide primers as described above are presently known to those skilled in the art.
  • the method can be performed with reference to Molecular Cloning, A Laboratory Manual, edited by T Maniatis, 2nd edition (1989), Cold Spring Harbor Laboratory, PCR A Practical Approach, IRL Press (1991).
  • kits and the like are commercially available for these reactions. Specifically, a PCR kit (Gibco BRL: PCR supermix, etc.) is used for the polymerase chain reaction, and an RT is used for the reverse transcription and the polymerase chain reaction.
  • -PCR kits (Gibco BRL, Superscript One-Step RT-PCR System, etc.) can be used.
  • the reaction conditions for the reverse transcription reaction and the polymerase chain reaction can be appropriately set based on the protocol attached to the above-mentioned basic manual kit.
  • the RT-PCR reaction for example, reverse rotation at 50 ° C for 30 minutes is performed.
  • the mRNA and single-stranded cDNA were heated at 94 ° C for 2 minutes. Separate, and then perform the PCR reaction at 94 ° C, 15 seconds ⁇ 60 ° C, 30 seconds ⁇ 72 ° C, 1 minute 40 times, and then perform the reaction at 72 ° C, 1 minute.
  • step (b) will be described.
  • the step (b) is a step of performing in vitro RNA synthesis using the DNA synthesized in the step (a) as a type III to prepare a specific RNA probe for the target gene.
  • step (b) can be performed directly using the synthetic DNA.
  • RNA is synthesized by converting the DNA synthesized in step (a) into type I, and reacting the substrate (NTPs) and RNA polymerase at 37 ° C for about 2 to 5 hours. Can be. At that time, it is preferable to carry out the above reaction in the presence of a ribonuclease inhibitor in order to avoid RNA degradation.
  • a hapten or a radiolabeled nucleotide as the substrate.
  • the hapten includes fluorescein (FITC) digoxigenin and the like
  • the radiolabel includes 32 P and the like.
  • RNA polymerase As the RNA polymerase, it is necessary to use an RNA polymerase that recognizes a promoter sequence present at the 5 ′ end of the DNA synthesized in the step (a).
  • the DNA (promoter + DNA) having a promoter sequence in both strands synthesized in step (a) is placed in two separate tubes. The reaction is performed by adding RNA polymerase for the synthesis of sense strand RNA to one side and RNA polymerase for the synthesis of antisense strand to the other side.
  • RNA polymerase used is T7 RNA polymerase, T3 RNA polymerase And SP6 RNA polymerase, all of which can be purchased from Roche.
  • RNA probe thus prepared is used for in situ hybridization, Northern plot hybridization, etc. after degrading type I DNA by adding deoxyribonuclease I. be able to.
  • FIG. 1 schematically shows a specific example of a method for producing a high-efficiency RNA probe through a series of steps (a) and (b).
  • Each setting in Fig. 1 is as follows.
  • 5'-oligonucleotide primer 5'-oligonucleotide primer with T3 RNA recognition sequence (T3 promoter-1) added to 5 'end
  • 3'-oligonucleotide primer 5, 3'-oligonucleotide primer with a T7 RNA recognition sequence (T7 promoter-1) at the end
  • Target gene-specific sequence length about 500 bp
  • Sense strand cRNA synthesized by T3 RNA polymerase
  • Antisense strand cRNA synthesized by T7 RNA polymerase
  • the present invention further encompasses an oligonucleotide primer having an RNA polymerase recognition sequence added to its 5 'end and a DNA synthesized using the oligonucleotide primer used in the step (a). Things. These primers and DNAs have never existed in the past because they are primers and synthetic DNAs with an RNA polymerase recognition sequence added to the end.These are the highly efficient RNA probes of the present invention. It is effectively used as a reagent for the production method.
  • RNA polymer it also includes a group of oligonucleotide primers to which a protease recognition sequence has been added, or a group of DNAs synthesized using the group of oligonucleotide primers.
  • oligonucleotide primers with a separate RNA polymerase recognition sequence at the 5 'end of the 5'- and 3,1 oligonucleotide primers, or a set of these oligonucleotide primers
  • DNA synthesized using the group or a group thereof is preferable.
  • oligonucleotide primers or groups thereof, or DNAs or groups synthesized using the oligonucleotide primers or groups thereof can also be used in the form of a kit for producing a highly efficient RNA probe.
  • the primer can be designed and synthesized, and DNA synthesis (PCR or RT-PCR) using the primer can be performed. It is possible to prepare an RNA probe for the gene or genes to be analyzed.
  • the kit is used very effectively when creating an in situ database.
  • the present invention also provides a reagent kit for producing a high-efficiency RNA probe, capable of performing the series of steps (a) and (b).
  • the kit contains the following reagents (i) and (ii).
  • RNA probes for a large number of target genes can be prepared simultaneously and in a short time by using the kit.
  • the term "enzyme necessary for the polymerase chain reaction” refers to a thermostable DNA polymerase
  • the term “reagent necessary for the polymerase chain reaction” refers to a buffer solution and a substrate solution that are optimal for expressing the activity of the enzyme. Point to. "The relaxation required for the polymerase chain reaction The “impact” includes, specifically, a solution of 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 50 mM KC1, 1 mM dNTP at the time of the reaction.
  • enzyme required for reverse transcription and polymerase chain reaction refers to reverse transcriptase and thermostable DNA polymerase, and “reagents required for reverse transcription and polymerase chain reaction”. It refers to a buffer solution and a substrate solution that are optimal for expressing the activity of the enzyme.
  • the “buffer necessary for reverse transcription and polymerase chain reaction” is, specifically, 50 mM Tris-HCl (pH 8.3), 5 mM MgCl 2 , 50 mM KC1, 1 mM DTT, 20 mM g / ml BSA, 1 mM dNTP solution and the like.
  • RNA polymerase T7, T3, SP6
  • deoxyribonuclease I RNA polymerase
  • buffer buffers optimal for the activity of the enzyme. Liquid, substrate solution (including hapten label).
  • Buffer refers to a solution of 40 raM Tris-HCl ( ⁇ 8.0), 20 mM MgCl 2 , 50 mM NaCl, 5 mM DTT, 1 mM NTP (including hapten label) at the concentration at the time of the reaction. And the like.
  • the target gene-specific RNA probe is prepared by the method of the present invention, the specific cRNA probes for 13 genes described below were prepared, i n situ High Priestess die See Chillon (hole using these Puropu Mounting method).
  • Semaphorin 3A (Genbank Acc.No.X95289), Semaphorin 6B (Genbank Acc.No.AB000776), Semaphorin 6C (Genbank Acc.No.AB000817), Neuropilin-1 (Genbank Acc. AF016296), Neuropilin-2 (Genbank Acc.No.AF016297), Plexin-Al (Genbank Acc.No.D86948), Pleki
  • A3 (Genbank Acc.No.D86950), Netrin-1 (Genbank Acc.No.AF128865), DCC (Genbank Acc.No.U68725), unc-5hl (Genbank Acc.No.U87305), Ephrin-Bl (Genbank Acc.No.U07560), Eph-Bl (Genbank Acc.No.X13411), and We chose Neurol Firament -M (Genbank Acc. No. Z12152).
  • oligonucleotide primers in which the base sequence of the 5'-end 20 base of each of the sense strand and the antisense strand of the 500 bp region specific to the target gene was attached downstream of the promoter sequence derived from pacterio phage was synthesized using a DNA synthesizer.
  • the sequences at the 5 bases and the 20 bases were determined by conducting a homology search using a database of genome sequences.
  • a T3 promoter (SEQ ID NO: 1) on the sense strand side and a T7 promoter (SEQ ID NO: 2) on the antisense strand side were used.
  • the 5′-PCR primer and 3′-PCR primer of semaphorin 3A are shown in SEQ ID NOs: 3 and 4, and the 5, -PCR primer and 3′-PCR primer of semaphorin 6B are shown in SEQ ID NOs: 5 and 6.
  • the 5'-PCR primer and 3'-PCR primer of semaphorin 6C are shown in SEQ ID NOs: 7 and 8, and the 5'-PCR primer and 3, -PCR primer of neuropilin-1 are shown in SEQ ID NOs: 9 and 10.
  • the 5'-PCR primer of neuropilin-2 and the-3 -PCR primer are shown in SEQ ID NOS: 11 and 12
  • the 5'-PCR primer of Plexin-A1 and the 3'-PCR primer are shown in SEQ ID NO:
  • Plexin-A3 5- and -primer 3'-PCR primers are shown in SEQ ID NOs: 15 and 16, Netrin-1 5- and -PCR primers and 3'-PCR primers 13 and 14.
  • 5'-PCR primer and 3'-PCR primer of DCC to SEQ ID NO: 17 and 18, respectively.
  • T3 promoter at the end of sense strand of synthesized cDNA And a T7 promoter is added to the 5 'end of the antisense strand (hereinafter, the cDNA with the promoter added is referred to as promoter + cDNA).
  • the synthesized promoter I ⁇ "hcDNA was recovered by ethanol precipitation after phenol: chlorophonolem treatment, and used for the following in vitro transcription reaction (cRNA probe synthesis) type II.
  • Honole mount in situ hybridization was performed according to the method described in Riddle et al. Cell 75, 1401-1416 (1993).
  • the pretreated embryonic rat embryos were immersed in a hybridization solution containing 100 ng / ml of the synthesized cRNA probe at a temperature of 70 ° C overnight. After washing the excess cRNA probe, the localization of the cRNA probe (mRNA) was visualized using the detection kit for FITC (fluorescein) labeled probe (Dako). The result is shown in figure 2. As a result, all the specific signals of the mRNAs of the 13 targeted genes could be detected. These were consistent with the distributions already reported in the literature, indicating that the RNA probe production method of the present invention functions effectively.
  • RNA probes for a large number of genes can be prepared simultaneously and in a short time.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un nouveau procédé permettant de fabriquer simultanément et rapidement des sondes d'ARN propres à certains gènes sans clonage d'ADN. Ce procédé comprend une série d'étapes consistant (1) à déclencher une réaction en chaîne de la polymérase ou une transcription inverse et une réaction en chaîne de la polymérase à l'aide d'un polynucléotide provenant d'un tissu ou de cellules d'un individu, afin de synthétiser des ADN à double brin propres aux gènes cibles; puis (2) à synthétiser les ARN in vitro à l'aide des ADN synthétisés lors de l'étape (1) pour fabriquer des sondes, de manière à obtenir des sondes d'ARN propres aux gènes cibles.
PCT/JP2001/005837 2000-07-06 2001-07-05 Procede hautement efficaces permettant de fabriquer des sondes d'arn WO2002004627A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001269451A AU2001269451A1 (en) 2000-07-06 2001-07-05 Highly efficient method of constructing rna probes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000204547 2000-07-06
JP2000-204547 2000-07-06

Publications (1)

Publication Number Publication Date
WO2002004627A1 true WO2002004627A1 (fr) 2002-01-17

Family

ID=18701791

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/005837 WO2002004627A1 (fr) 2000-07-06 2001-07-05 Procede hautement efficaces permettant de fabriquer des sondes d'arn

Country Status (2)

Country Link
AU (1) AU2001269451A1 (fr)
WO (1) WO2002004627A1 (fr)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BLAIS B.W. ET AL.: "A simple RNA probe system for analysis of listeria monocytogenes polymerase chain reaction products", APPL. ENVIRON. MICROBIOL., vol. 59, no. 9, 1993, pages 2795 - 2800, XP002947584 *
LOGEL J. ET AL.: "Synthesis of cRNA probes from PCR-generated DNA", BIOTECHNIQUES, vol. 13, no. 4, 1992, pages 604 - 610, XP002947579 *
URRUTIA R. ET AL.: "Synthesis of RNA probes by the direct in vitro transcription of PCR-generated DNA templates", J. BIOCHEM. BIOPHYS. METHODS, vol. 26, no. 2-3, 1993, pages 113 - 120, XP002947580 *

Also Published As

Publication number Publication date
AU2001269451A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
US20210062244A1 (en) Nucleic acid amplification
Carulli et al. High throughput analysis of differential gene expression
JP4043516B2 (ja) 全長ｃＤＮＡクローニングのための方法及び組成物
JP3150061B2 (ja) 遺伝子発現分析方法
US6066457A (en) Global amplification of nucleic acids
US20030175908A1 (en) Methods and means for manipulating nucleic acid
US20030104432A1 (en) Methods of amplifying sense strand RNA
WO2000075356A1 (fr) Amplification en chaine d'arn par polymerase
JPH07500735A (ja) メッセンジャーｒｎａの同定、単離およびクローニング
JP2004504059A (ja) 転写された遺伝子を分析、及び同定するための方法、及びフインガープリント法
CN110719957A (zh) 用于核酸靶向富集的方法和试剂盒
WO2013079649A1 (fr) Procédé et kit pour la caractérisation d'arn dans une composition
US6706476B1 (en) Process for amplifying and labeling single stranded cDNA by 5′ ligated adaptor mediated amplification
EP1275738A1 (fr) Procédé pour la synthèse aléatoire et l'amplification d'ADNc
EP1608784B1 (fr) Amplification globale lineaire non biaisee d'acide nucleique
US20040142337A1 (en) Method of constructing cdna tag for identifying expressed gene and method of analyzing gene expression
JP2003093058A (ja) ランダムｃＤＮＡ増幅のための改善された方法
JP2010535529A (ja) マイクロアレイ製造用３’ベースシークエンシング手法
US20060240431A1 (en) Oligonucletide guided analysis of gene expression
JP2004187606A (ja) 核酸アイソフォームの同定、分析および／またはクローニング方法
WO2002004627A1 (fr) Procede hautement efficaces permettant de fabriquer des sondes d'arn
JP2002065263A (ja) ｃＤＮＡの増幅方法及び標識ｃＤＮＡの調製方法
EP1371726A1 (fr) Procédé d'amplification d'ARN
JP2002051784A (ja) 核酸の増幅方法及び標識核酸の調製方法
JP2002142765A (ja) 新規ゲノム解析法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 509481

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase